Tyme Technologies
TYME Inc. is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have tolerable toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Companyâ??s therapeutic approach is designed to take advantage of a cancer cellâ??s innate metabolic requirements to compromise its defenses, leading to cell death through oxidative stress and exposure to the bodyâ??s immune system.
What If You Bought TYME Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Sep 26, 2014 | — | 4-for-1 | 4× | 4× |
Tyme Technologies Market Cap Timeline
Validated annual market-cap history is available from 2013. Split markers cover all 1 recorded split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.